• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Can endothelial progenitor cells treat patients with refractory angina?内皮祖细胞能治疗难治性心绞痛患者吗？
Circ Res. 2014 Nov 7;115(11):904-7. doi: 10.1161/CIRCRESAHA.114.305284.
2
Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial.选择 CD133⁺ 祖细胞促进难治性心绞痛患者的血管生成：PROGENITOR 随机试验的最终结果。
Circ Res. 2014 Nov 7;115(11):950-60. doi: 10.1161/CIRCRESAHA.115.303463. Epub 2014 Sep 17.
3
Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.骨髓来源的自体CD133 +干细胞治疗的安全性和有效性。
Front Biosci (Elite Ed). 2011 Jan 1;3(2):506-14. doi: 10.2741/e265.
4
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.RENEW 试验：心肌内自体 CD34(+)细胞给药治疗难治性心绞痛的疗效和安全性。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1576-85. doi: 10.1016/j.jcin.2016.05.003.
5
MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma.MRI 示踪 FePro 标记的新鲜和冷冻保存的长期体外扩增人脐血 AC133+内皮祖细胞在大鼠胶质瘤中。
PLoS One. 2012;7(5):e37577. doi: 10.1371/journal.pone.0037577. Epub 2012 May 25.
6
Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.人胚干细胞源性 CD133+内皮祖细胞移植治疗性血管生成修复心肌。
Regen Med. 2010 Mar;5(2):231-44. doi: 10.2217/rme.09.83.
7
Glucose variability inversely associates with endothelial progenitor cells in type 1 diabetes.1型糖尿病患者的血糖变异性与内皮祖细胞呈负相关。
Endocrine. 2015 Feb;48(1):342-5. doi: 10.1007/s12020-014-0277-z. Epub 2014 May 7.
8
MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia.MAPC 移植比 AC133+细胞移植在严重下肢缺血中具有更持久的益处。
Cell Transplant. 2011;20(2):259-69. doi: 10.3727/096368910X516592. Epub 2010 Aug 17.
9
Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up.外周血内皮祖细胞（CD133 +）用于治疗严重肢体缺血患者的血管生成。一年随访。
Cytotherapy. 2007;9(1):99-102. doi: 10.1080/14653240601034708.
10
CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo.富含CD34/CD133的骨髓祖细胞促进体内组织工程构建体的新血管形成。
Stem Cell Res. 2014 Nov;13(3 Pt A):465-77. doi: 10.1016/j.scr.2014.10.005. Epub 2014 Oct 22.

引用本文的文献

1
Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant.左心室辅助装置桥接移植的缺血性心肌病中骨髓源性细胞治疗的机制
J Am Coll Cardiol. 2015 Apr 14;65(14):1424-34. doi: 10.1016/j.jacc.2015.01.042.

本文引用的文献

1
Selected CD133⁺ progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial.选择 CD133⁺ 祖细胞促进难治性心绞痛患者的血管生成：PROGENITOR 随机试验的最终结果。
Circ Res. 2014 Nov 7;115(11):950-60. doi: 10.1161/CIRCRESAHA.115.303463. Epub 2014 Sep 17.
2
Treatment of refractory angina in patients not suitable for revascularization.治疗不适宜血运重建的难治性心绞痛。
Nat Rev Cardiol. 2014 Feb;11(2):78-95. doi: 10.1038/nrcardio.2013.200. Epub 2013 Dec 24.
3
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.经心内膜心肌间质干细胞和单核骨髓细胞治疗缺血性心肌病：TAC-HFT 随机试验。
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
4
Immunobiology of mesenchymal stem cells.间充质干细胞的免疫生物学
Cell Death Differ. 2014 Feb;21(2):216-25. doi: 10.1038/cdd.2013.158. Epub 2013 Nov 1.
5
Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials.干细胞疗法是治疗难治性心绞痛的有前途的工具：随机对照试验的荟萃分析。
Can J Cardiol. 2013 Aug;29(8):908-14. doi: 10.1016/j.cjca.2012.12.003. Epub 2013 Mar 5.
6
Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy.简明综述：临床试验在破译基于心脏细胞的治疗作用机制中的作用。
Stem Cells Transl Med. 2012 Jan;1(1):29-35. doi: 10.5966/sctm.2011-0014. Epub 2011 Dec 7.
7
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.经心内膜注射异体与自体骨髓间充质干细胞治疗缺血性心肌病的比较：POSEIDON 随机试验。
JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.
8
Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up.直接心肌内间质基质细胞注射治疗严重难治性心绞痛患者：一年随访。
Cell Transplant. 2013;22(3):521-8. doi: 10.3727/096368912X636830. Epub 2012 Apr 2.
9
One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction.COMPARE-AMI试验的一年安全性分析：急性心肌梗死和左心室功能障碍患者冠状动脉内注射CD133骨髓干细胞与安慰剂的比较。
Bone Marrow Res. 2011;2011:385124. doi: 10.1155/2011/385124. Epub 2011 Feb 27.
10
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.间质干细胞：生物学、病理生理学、转化研究结果以及在心脏疾病中的治疗意义。
Circ Res. 2011 Sep 30;109(8):923-40. doi: 10.1161/CIRCRESAHA.111.243147.

Can endothelial progenitor cells treat patients with refractory angina?

作者信息

Premer Courtney, Hare Joshua M

机构信息

From the Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, FL.

出版信息

Circ Res. 2014 Nov 7;115(11):904-7. doi: 10.1161/CIRCRESAHA.114.305284.

DOI:10.1161/CIRCRESAHA.114.305284
PMID:25378530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4284967/
Abstract
摘要